Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

More On HIK.L



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


Hikma Pharmaceuticals plc (HIK.L)

1,787.00 Up 76.00(4.44%) 11:35AM EDT
ProfileGet Profile for:
Hikma Pharmaceuticals plc
13 Hanover Square
London, W1S 1HW
United Kingdom - Map
Phone: 44 20 7399 2760
Fax: 44 20 7399 2761

Index Membership:N/A
Industry:Drugs - Generic
Full Time Employees:7,067

Business Summary 

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, and Europe. It operates through three segments: Branded, Injectable, and Generic. The Branded segment offers 499 products in 1,256 dosage strengths and forms, which lie in the anti-infective, cardiovascular, central nervous system (CNS), and diabetes therapeutic areas. The Injectables segment markets 200 branded and non-branded products in 379 dosage strengths and forms with a focus on CNS, anti-infective, musculoskeletal, cardiovascular, and oncological therapeutic areas. This segment also offers sterile liquid, powder, lyophilized, and cytotoxic products. The Generics segment provides 11 products in 44 dosage strengths and forms for various therapeutic areas including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory, hormonal, and others. This segment markets its products to chain stores, wholesalers, distributors, health systems, and governmental agencies in the form of tablets, capsules, solutions, and suspensions. In addition, the company offers anesthetics, anti-histamines, gastroenterology and metabolism, dermatology, genitourinary system, transplantation, vitamins and supplements, and miscellaneous products. Further, it manufactures plastic specialized medicinal sterile containers and API; and conducts bio-equivalency studies. The company was founded in 1978 and is based in London, the United Kingdom.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Hikma Pharmaceuticals plc

Key Executives 
Mr. Said Samih Taleb Darwazah , 57
Chairman and Chief Exec. Officer
Mr. Mazen Samih Taleb Darwazeh , 56
Exec. Vice Chairman, Chief Exec. Officer of MENA & Emerging Markets, Pres of MENA & Emerging Markets, Member of Nomination Committee and Member of Compliance, Responsibility & Ethics Committee
Mr. Samih Darwazah , 83
Founder and Honorary Life Pres
Mr. Khalid Nabilsi ,
Chief Financial Officer
Dr. Ibrahim Jalal ,
Sr. Corp. VP of Technical Affairs
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in GBp.